Skip to main content

Publisher: Palgrave Macmillan

Volume 16, Number 4, 1 October 2010

For success in biotechnology, look beyond biotechnology
pp. 279-280(2)
Author: Friedman, Yali

Favourites:
ADD

Federal bureaucrats slip on oil spill
pp. 281-283(3)
Author: Miller, Henry I

Favourites:
ADD

R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public
pp. 284-292(9)
Authors: Williams, David R; Pouder, Richard W

Favourites:
ADD

Algae and Biodiesel: Patenting energized as green goes commercial
pp. 293-312(20)
Authors: Preiss, Matthew R; Kowalski, Stanley P

Favourites:
ADD

Biotechnology industry-physician interaction and OIG guidelines: Evidence from the stock market
pp. 313-330(18)
Authors: Jambulingam, Thani; Ghani, WaQar; Sharma, Rajneesh

Favourites:
ADD

Exploratory assessment of the current EU regulatory framework for development of advanced therapies
pp. 331-336(6)
Authors: Singh, Pawanbir; Brévignon-Dodin, Laure; Dash, Satya P

Favourites:
ADD

Patenting of microorganisms: Systems and concerns
pp. 337-347(11)
Authors: Balachandra Nair, Ramkumar; Ramachandranna, Pratap Chandran

Favourites:
ADD

Legal and Regulatory Update
pp. 348-357(10)

Favourites:
ADD

The aftermath of Bilski
pp. 358-359(2)
Authors: Meyers, Thomas C; Schoen, Adam M

Favourites:
ADD

Commentary regarding decision in Bilski from a biotech perspective
pp. 360-361(2)
Authors: Kowalski, Thomas J; Lunasin, Heidi E; Lu, Deborah L; McGuire, Brian M; DeRosa, Frank J

Favourites:
ADD

Biodesign: The process of innovating medical technologies
pp. 362-364(3)
Authors: Tagg, Randall; Bravo, Catalina

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more